Home - REBEL EM - Emergency Medicine Blog

The ADAPT-Sepsis Trial: Biomarker-Guided Antibiotic Duration for Hospitalized Patients with Suspected Sepsis

by Mark Ramzy posted June 9, 2025 No Comments

Antibiotic stewardship entails delivering the most appropriate antimicrobial therapy for the most appropriate duration of time to help provide the best outcome for patients with sepsis. An unnecessarily extended course ...

Infectious Disease

The ADAPT-Sepsis Trial: Biomarker-Guided Antibiotic Duration for Hospitalized Patients with Suspected Sepsis

Latest Posts

March 31: Levitan/Rezaie Practical Airway Course

Clinical Conundrum: Do I Have to Replace the Nail After an Avulsion?

IVC Distensibility Index vs Collapsibility Index: Using the Correct Index

Latest Posts

Automated vs Manual Chest Compressions in Out-of-Hospital Cardiac Arrest

DanGer Shock Trial: Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock

Don’t Forget About the IO in the Critically Ill Patient

The ACORN Trial: Battle of the Gorilla-Cillins (Cefepime vs Piperacillin-Tazobactam)

Latest Episode

REBEL Core Cast 136.0: A Simple Approach to the Tachypneic Patient

Recent Episodes

REBEL Core Cast 135.0: A Simple Approach to Hypoxemia (vs. Hypoxia)

REBEL Core Cast 134.0 – Acetaminophen Toxicity

Street Medicine: Compassionate Care for the Unhoused

Latest Review

MDCalc Wars: Canadian C-Spine Rules Cheat Sheet

Recent Reviews

MDCalc Wars: Nexus Criteria Cheat Sheet

REBEL Review 108: High-Dose Nitroglycerin for Sympathetic Crashing Acute Pulmonary Edema

REBEL Review 107: D5, D10, & D20 Made Simple

The REBEL Lit Distillery at ResusX

Clinical Conundrums: Is an Arterial Lactate Necessary?

The PREOXI Trial: Pre-Oxygenation with NIV vs Facemask

REBEL Core Cast 126.0 – Peds Hem Onc Emergencies

REBEL Core Cast 125.0 – Hyperkalemia

REBEL Core Cast 124.0 – Hyperinsulinemia Euglycemia Therapy

REBEL Core Cast 123.0 – Posterior Epistaxis

REBEL EM is licensed under a